Imunon Inc. (IMNN)
IMNN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.07
0.00% on the day
Market cap
$6.0M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | IMNN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000749647 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2022-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-03-23 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEF 14A | 2026-05-04 |
Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BGMS | Bio Green Med Solution Inc. | $0.9199 | -7.08% | $6.1M |
| CANF | Can-Fite Biopharma Ltd | $1.95 | 0.00% | $5.9M |
| LEXX | Lexaria Bioscience Corp. | $2.80 | -14.37% | $5.9M |
| MDCX | Medicus Pharma Ltd. Common Stock | $3.28 | -8.38% | $5.9M |
| ENVB | Enveric Biosciences Inc. | $1.40 | -4.76% | $6.3M |
| TRAW | Traws Pharma Inc. | $0.4101 | -1.42% | $6.3M |
| FBLG | FibroBiologics Inc. | $0.9599 | -4.01% | $6.5M |
| ALZN | Alzamend Neuro Inc. | $1.35 | +3.05% | $6.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier